AU2001260661A1 - Compounds exhibiting thrombopoietin-like activities - Google Patents

Compounds exhibiting thrombopoietin-like activities

Info

Publication number
AU2001260661A1
AU2001260661A1 AU2001260661A AU6066101A AU2001260661A1 AU 2001260661 A1 AU2001260661 A1 AU 2001260661A1 AU 2001260661 A AU2001260661 A AU 2001260661A AU 6066101 A AU6066101 A AU 6066101A AU 2001260661 A1 AU2001260661 A1 AU 2001260661A1
Authority
AU
Australia
Prior art keywords
activities
compounds exhibiting
exhibiting thrombopoietin
thrombopoietin
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260661A
Inventor
Toru Esaki
Shinya Fujiwara
Kunihiro Hattori
Toshiro Kozono
Tomokazu Ozaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU2001260661A1 publication Critical patent/AU2001260661A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001260661A 2000-05-30 2001-05-30 Compounds exhibiting thrombopoietin-like activities Abandoned AU2001260661A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000161036 2000-05-30
JP2000-161036 2000-05-30
PCT/JP2001/004561 WO2001092211A1 (en) 2000-05-30 2001-05-30 Compounds exhibiting thrombopoietin-like activities

Publications (1)

Publication Number Publication Date
AU2001260661A1 true AU2001260661A1 (en) 2001-12-11

Family

ID=18665138

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260661A Abandoned AU2001260661A1 (en) 2000-05-30 2001-05-30 Compounds exhibiting thrombopoietin-like activities

Country Status (6)

Country Link
US (1) US6887890B2 (en)
EP (1) EP1291341A4 (en)
JP (1) JP3966816B2 (en)
AU (1) AU2001260661A1 (en)
TW (1) TWI282785B (en)
WO (1) WO2001092211A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096154A2 (en) 2003-04-29 2004-11-11 Smithkline Beecham Corporation Methods for treating degenerative diseases/injuries
WO2007044982A2 (en) * 2005-10-13 2007-04-19 Smithkline Beecham Corporation Methods for the preservation of platelet efficacy during storage
CA2630234A1 (en) * 2005-11-23 2007-05-31 Ligand Pharmaceuticals Inc. Thrombopoietin activity modulating compounds and methods
US7879318B2 (en) 2006-01-23 2011-02-01 Mcw Research Foundation, Inc. Method of reducing the effects of ischemia by administration of a thrombopoietin receptor ligand
EP2079687A1 (en) * 2006-12-18 2009-07-22 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
US20110129550A1 (en) * 2007-02-16 2011-06-02 Connie Erickson-Miller Cancer treatment method
US20110160130A1 (en) * 2007-02-16 2011-06-30 Connie Erickson-Miller Cancer treatment method
UY30915A1 (en) * 2007-02-16 2008-09-02 Smithkline Beecham Corp CANCER TREATMENT METHOD
KR101530402B1 (en) * 2007-10-09 2015-06-19 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 Thrombopoietin receptor agonist (tpora) kills acute human myeloid leukemia cells
US8476249B2 (en) 2009-05-07 2013-07-02 Glaxosmithkline Llc Method of treating thrombocytopenia
PT2488486T (en) * 2009-10-13 2019-11-05 Ligand Pharm Inc Hematopoietic growth factor mimetic small molecule compounds and their uses
MX2018003301A (en) 2015-09-17 2019-02-07 Pcna inhibitors.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3415103A1 (en) 1984-04-21 1985-10-31 Bayer Ag, 5090 Leverkusen METHOD FOR FLUORESCENT EXTINGUISHING AND NEW CATIONIC AROMATIC NITRO COMPOUNDS
JPH01261650A (en) * 1988-04-13 1989-10-18 Canon Inc Electrophotographic sensitive body
NZ310778A (en) 1995-06-07 1999-10-28 Glaxo Group Ltd Peptides and compounds that bind to a thrombopoietin receptor
JPH10212289A (en) 1997-01-31 1998-08-11 Kyowa Hakko Kogyo Co Ltd Pyrrolophenanthridine derivative
JPH111477A (en) 1997-06-12 1999-01-06 Hokuriku Seiyaku Co Ltd 1,4-benzodiazepine and use thereof
JPH11152276A (en) 1997-11-20 1999-06-08 Hokuriku Seiyaku Co Ltd Benzodiazepine derivative
ATE315390T1 (en) 1998-11-17 2006-02-15 Smithkline Beecham Corp CYCLIC POLYAMINES FOR THE TREATMENT OF THROMBOCYTOPENIA
GC0000177A (en) 1998-12-17 2006-03-29 Smithkline Beecham Thrombopoietin mimetics
WO2000066112A1 (en) 1999-05-03 2000-11-09 Smithkline Beecham Corporation Cxcr-4 receptor antagonists - thrombopoietin mimetics
KR20020069183A (en) 1999-07-26 2002-08-29 시오노기세이야쿠가부시키가이샤 Drug compositions exhibiting thrombopoietin agonism
JP4488663B2 (en) 1999-09-10 2010-06-23 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Thrombopoietin mimetic
DE60032783T2 (en) 1999-09-24 2007-12-06 Smithkline Beecham Corp. THROMBOPOIETINMIMETIKA
AU1462201A (en) 1999-11-05 2001-06-06 Smithkline Beecham Corporation Semicarbazone derivatives and their use as thrombopoietin mimetics

Also Published As

Publication number Publication date
WO2001092211A1 (en) 2001-12-06
US6887890B2 (en) 2005-05-03
US20030162724A1 (en) 2003-08-28
EP1291341A1 (en) 2003-03-12
EP1291341A4 (en) 2005-04-27
TWI282785B (en) 2007-06-21
JP3966816B2 (en) 2007-08-29

Similar Documents

Publication Publication Date Title
AU2002218266A1 (en) Novel indanylidene compounds
AU2002225730A1 (en) Compounds
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001292518A1 (en) Novel compounds
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001266345A1 (en) Five-membered-ring compound
AU2001258349A1 (en) Bisacylguanidine
AUPQ661800A0 (en) Insulin-potentiating compounds
AU2001239765A1 (en) Novel compounds
AU2001246998A1 (en) Novel compounds
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001253362A1 (en) Novel compounds
AU2001258924A1 (en) Microsatellite-aflp
AU2001260661A1 (en) Compounds exhibiting thrombopoietin-like activities
AU2001254731A1 (en) Substituted phenyluracils
AU2002231077A1 (en) Novel compounds
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001256964A1 (en) Novel compounds
AU2002225724A1 (en) Motilide compounds
AU2002217285A1 (en) Compounds
AU2001230689A1 (en) Novel compounds
AU2001246864A1 (en) Hypotensors
AU2002221923A1 (en) Novel compounds